Need Help?

Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients

We integrate genomic (whole-genome sequencing, WGS) and transcriptome (polyA-enriched RNA-Seq) sequencing from 90 NSCLC cases and comprehensively identified the distinct genomic features of Chinese NSCLC patients.

Request Access

General data access agreement

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom XXXXX grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: XXXXX and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. XXXXX: Your Institution details here 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify XXXXX within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify XXXXX prior to any significant changes to the protocol for the Project. 14. The User Institution will notify XXXXX as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. XXXXX may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than XXXXX. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Chinese and shall be subject to the exclusive jurisdiction of the Chinese courts. 20. The User Institution agrees to follow the Guidance of the Ministry of Science and Technology (MOST) for the Review and Approval of Human Genetic Resources (http://www.most.gov.cn/fggw/xzfg/200811/t20081106_64877.htm).

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00001992614 vcf 281.9 kB
EGAF00001992615 vcf 789.3 kB
EGAF00001992616 vcf 259.1 kB
EGAF00001992617 vcf 503.5 kB
EGAF00001992618 vcf 727.1 kB
EGAF00001992619 vcf 1.8 MB
EGAF00001992620 vcf 50.0 kB
EGAF00001992621 vcf 143.1 kB
EGAF00001992622 vcf 96.5 kB
EGAF00001992623 vcf 72.1 kB
EGAF00001992624 vcf 1.2 MB
EGAF00001992625 vcf 569.1 kB
EGAF00001992626 vcf 1.4 MB
EGAF00001992627 vcf 172.0 kB
EGAF00001992628 vcf 80.4 kB
EGAF00001992629 vcf 511.8 kB
EGAF00001992630 vcf 884.5 kB
EGAF00001992631 vcf 1.2 MB
EGAF00001992632 vcf 2.0 MB
EGAF00001992633 vcf 173.2 kB
EGAF00001992634 vcf 152.3 kB
EGAF00001992635 vcf 319.3 kB
EGAF00001992636 vcf 154.1 kB
EGAF00001992637 vcf 59.4 kB
EGAF00001992638 vcf 377.5 kB
EGAF00001992639 vcf 4.7 MB
EGAF00001992640 vcf 29.2 kB
EGAF00001992641 vcf 1.3 MB
EGAF00001992642 vcf 449.2 kB
EGAF00001992643 vcf 78.6 kB
EGAF00001992644 vcf 1.5 MB
EGAF00001992645 vcf 190.8 kB
EGAF00001992646 vcf 155.4 kB
EGAF00001992647 vcf 1.1 MB
EGAF00001992648 vcf 161.7 kB
EGAF00001992649 vcf 149.7 kB
EGAF00001992650 vcf 888.0 kB
EGAF00001992651 vcf 376.1 kB
EGAF00001992652 vcf 299.2 kB
EGAF00001992653 vcf 896.0 kB
EGAF00001992654 vcf 2.2 MB
EGAF00001992655 vcf 157.7 kB
EGAF00001992656 vcf 1.1 MB
EGAF00001992657 vcf 1.6 MB
EGAF00001992658 vcf 1.1 MB
EGAF00001992659 vcf 617.6 kB
EGAF00001992660 vcf 305.6 kB
EGAF00001992661 vcf 1.1 MB
EGAF00001992662 vcf 135.4 kB
EGAF00001992663 vcf 45.4 kB
EGAF00001992664 vcf 281.1 kB
EGAF00001992665 vcf 3.0 MB
EGAF00001992666 vcf 86.9 kB
EGAF00001992667 vcf 250.0 kB
EGAF00001992668 vcf 150.4 kB
EGAF00001992669 vcf 113.8 kB
EGAF00001992670 vcf 53.1 kB
EGAF00001992671 vcf 128.4 kB
EGAF00001992672 vcf 807.7 kB
EGAF00001992673 vcf 94.8 kB
EGAF00001992674 vcf 172.5 kB
EGAF00001992675 vcf 223.6 kB
EGAF00001992676 vcf 78.7 kB
EGAF00001992677 vcf 502.4 kB
EGAF00001992678 vcf 1.7 MB
EGAF00001992679 vcf 2.1 MB
EGAF00001992680 vcf 1.3 MB
EGAF00001992681 vcf 176.5 kB
EGAF00001992682 vcf 1.4 MB
EGAF00001992683 vcf 331.4 kB
EGAF00001992684 vcf 98.7 kB
EGAF00001992685 vcf 1.6 MB
EGAF00001992686 vcf 1.0 MB
EGAF00001992687 vcf 166.8 kB
EGAF00001992688 vcf 1.2 MB
EGAF00001992689 vcf 1.0 MB
EGAF00001992690 vcf 72.4 kB
EGAF00001992691 vcf 66.7 kB
EGAF00001992692 vcf 345.4 kB
EGAF00001992693 vcf 91.0 kB
EGAF00001992694 vcf 1.5 MB
EGAF00001992695 vcf 200.0 kB
EGAF00001992696 vcf 494.2 kB
EGAF00001992697 vcf 223.9 kB
EGAF00001992698 vcf 57.5 kB
EGAF00001992699 vcf 282.8 kB
EGAF00001992700 vcf 822.2 kB
EGAF00001992701 vcf 82.1 kB
EGAF00001992702 vcf 2.2 MB
EGAF00001992703 vcf 444.2 kB
90 Files (59.3 MB)